A Randomized, Phase 1, Placebo-controlled, Double-blind, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Subcutaneously and Intravenously Delivered Anifrolumab in Healthy Subjects.
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008212/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase I, Randomized, Placebo-Controlled, Double-Blind Study to Assess the
Pharmacokinetics and Safety of anifrolumab following Single-Dose administration to healthy
subjects
提供机构：
Vivli
创建时间：
2022-07-06
